Figure 5

Plasma levels of miR-21, miR-128 and miR-342-3p in normal cohorts, meningioma cohorts, pituitary adenoma cohorts and glioma cohorts. (A) Plasma levels of miR-21 are significantly increased in glioma samples compared to control samples, (B) and (C) levels of miR-128 and miR-342-3p are markedly reduced in glioma samples compared to control samples. But there was no significant difference between controls and meningioma patients or pituitary adenoma patients (P > 0.05). ^*P < 0.008 in comparison with normal, ^#P < 0.008 in comparison with meningioma, ^△P < 0.008 in comparison with pituitary adenoma.